F. Wink

764 citations

44 papers · 521 indexed · h-index 14

Impact in

Rheumatology top 2%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
Orthopedics and Sports Medicine top 5%
- Bone and Joint Diseases

Papers in ⓘ

Rheumatology 38
- Spondyloarthritis Studies and Treatments 37
- Rheumatoid Arthritis Research and Therapies 18
Immunology 22
- Psoriasis: Treatment and Pathogenesis 22

Co-authors: Suzanne Arends (39 shared papers)Anneke Spoorenberg (39 shared papers)Hendrika Bootsma (20 shared papers)F. Maas (18 shared papers)Elisabeth Brouwer (12 shared papers)E. van der Veer (11 shared papers)Reinhard Bos (14 shared papers)M. Efdé (4 shared papers)
Journals: Annals of the Rheumatic Diseases (9 papers)Seminars in Arthritis and Rheumatism (7 papers)PLoS ONE (4 papers)Arthritis Research & Therapy (3 papers)Arthritis Care & Research (3 papers)
Partner nations: Netherlands United States Italy

In The Last Decade

F. Wink

39 papers receiving 511 citations

Peers

Countries citing papers authored by F. Wink

Since Specialization

Citations

This map shows the geographic impact of F. Wink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Wink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Wink more than expected).

Fields of papers citing papers by F. Wink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Wink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Wink. The network helps show where F. Wink may publish in the future.

Co-authors

The 25 scholars most cited alongside F. Wink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with F. Wink Line = papers co-authored together F. Wink links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Reduction in Spinal Radiographic Progression in Ankylosing Spondylitis Patients Receiving Prolonged Treatment With Tumor Necrosis Factor Inhibitors Arthritis Care & Research ·F. Maas, Suzanne Arends, Elisabeth Brouwer, Ivette Essers, E. van der Veer, M. Efdé, Peter M. A. van Ooijen, Rinze Wolf, Nic J.G.M. Veeger, Hendrika Bootsma, F. Wink, Anneke Spoorenberg	2016	71
2	Obesity Is Common in Axial Spondyloarthritis and Is Associated with Poor Clinical Outcome The Journal of Rheumatology ·F. Maas, Suzanne Arends, E. van der Veer, F. Wink, M. Efdé, Hendrika Bootsma, Elisabeth Brouwer, Anneke Spoorenberg	2015	66
3	Clinical Risk Factors for the Presence and Development of Vertebral Fractures in Patients With Ankylosing Spondylitis Arthritis Care & Research ·F. Maas, Anneke Spoorenberg, Boukje P. G. van der Slik, E. van der Veer, Elisabeth Brouwer, Hendrika Bootsma, Reinhard Bos, F. Wink, Suzanne Arends	2016	40
4	Central sensitization, illness perception and obesity should be considered when interpreting disease activity in axial spondyloarthritis Lara D. Veeken ·S. Kieskamp, Davy Paap, M. Carbo, F. Wink, Reinhard Bos, Hendrika Bootsma, Suzanne Arends, Anneke Spoorenberg	2021	33
5	Ankylosing spondylitis patients at risk of poor radiographic outcome show diminishing spinal radiographic progression during long-term treatment with TNF-α inhibitors PLoS ONE ·F. Maas, Suzanne Arends, F. Wink, Reinhard Bos, Hendrika Bootsma, Elisabeth Brouwer, Anneke Spoorenberg	2017	30
6	Central sensitization has major impact on quality of life in patients with axial spondyloarthritis Seminars in Arthritis and Rheumatism ·S. Kieskamp, Davy Paap, M. Carbo, F. Wink, Reinhard Bos, Hendrika Bootsma, Suzanne Arends, Anneke Spoorenberg	2021	27
7	Long-term drug survival and clinical effectiveness of etanercept treatment in patients with ankylosing spondylitis in daily clinical practice. PubMed ·Suzanne Arends, Liesbeth Brouwer, M. Efdé, E. van der Veer, Hendrika Bootsma, F. Wink, Anneke Spoorenberg	2017	25
8	High prevalence of hidradenitis suppurativa symptoms in axial spondyloarthritis patients: A possible new extra-articular manifestation Seminars in Arthritis and Rheumatism ·Angelique Rondags, Suzanne Arends, F. Wink, Barbara Horváth, Anneke Spoorenberg	2018	24
9	Rituximab in cryoglobulinaemic vasculitis, evidence for its effectivity: a case report and review of literature Clinical Rheumatology ·F. Wink, P. M. Houtman, Tim Jansen	2010	24
10	Radiographic damage and progression of the cervical spine in ankylosing spondylitis patients treated with TNF-α inhibitors: Facet joints vs. vertebral bodies Seminars in Arthritis and Rheumatism ·F. Maas, Anneke Spoorenberg, Elisabeth Brouwer, E. van der Veer, Hendrika Bootsma, Reinhard Bos, F. Wink, Suzanne Arends	2016	23
11	Incorporating assessment of the cervical facet joints in the modified Stoke ankylosing spondylitis spine score is of additional value in the evaluation of spinal radiographic outcome in ankylosing spondylitis Arthritis Research & Therapy ·F. Maas, Suzanne Arends, Elisabeth Brouwer, Hendrika Bootsma, Reinhard Bos, F. Wink, Anneke Spoorenberg	2017	18
12	Validity and Reliability of the Dutch Adaptation of the Psoriatic Arthritis Quality of Life (PsAQoL) Questionnaire PLoS ONE ·F. Wink, Suzanne Arends, Stephen P. McKenna, P. M. Houtman, Elisabeth Brouwer, Anneke Spoorenberg	2013	18
13	Ankylosing spondylitis disease activity score is related to NSAID use, especially in patients treated with TNF-α inhibitors PLoS ONE ·M. Carbo, Anneke Spoorenberg, F. Maas, Elisabeth Brouwer, Reinhard Bos, Hendrika Bootsma, E. van der Veer, F. Wink, Suzanne Arends	2018	14
14	Uncovering the heterogeneity of disease impact in axial spondyloarthritis: bivariate trajectories of disease activity and quality of life RMD Open ·Maike Imkamp, Valéria Lima Passos, Annelies Boonen, Suzanne Arends, Maxime Dougados, Robert Landewé, Sofía Ramiro, Filip Van den Bosch, Désirée van der Heijde, F. Wink, Anneke Spoorenberg, Astrid van Tubergen	2018	13
15	Baseline serum biomarkers of inflammation, bone turnover and adipokines predict spinal radiographic progression in ankylosing spondylitis patients on TNF inhibitor therapy Seminars in Arthritis and Rheumatism ·Judith Rademacher, M. Siderius, Laura Gellert, F. Wink, М. Verba, F. Maas, Lorraine Madeline Tietz, Denis Poddubnyy, Anneke Spoorenberg, Suzanne Arends	2022	13
16	The mSQUASH; a valid, reliable and responsive questionnaire for daily physical activity in patients with axial spondyloarthritis Seminars in Arthritis and Rheumatism ·M. Carbo, Davy Paap, F. Maas, Anna Jetske Baron, Laura C van Overbeeke, M. Siderius, Hendrika Bootsma, F. Wink, Suzanne Arends, Anneke Spoorenberg	2021	12
17	Radiographic vertebral fractures develop in patients with ankylosing spondylitis during 4 years of TNF-α blocking therapy. PubMed ·F. Maas, Anneke Spoorenberg, Elisabeth Brouwer, Anna M Schilder, R.N. Chaudhry, F. Wink, Hendrika Bootsma, E. van der Veer, Suzanne Arends	2016	12
18	Although female patients with ankylosing spondylitis score worse on disease activity than male patients and improvement in disease activity is comparable, male patients show more radiographic progression during treatment with TNF-α inhibitors Seminars in Arthritis and Rheumatism ·Boukje van der Slik, Anneke Spoorenberg, F. Wink, Reinhard Bos, Hendrika Bootsma, F. Maas, Suzanne Arends	2018	11
19	High prevalence of hip involvement and decrease in inflammatory ultrasound lesions during tumour necrosis factor-α blocking therapy in ankylosing spondylitis Lara D. Veeken ·F. Wink, Suzanne Arends, F. Maas, Hendrika Bootsma, E. N. Griep, George A W Bruyn, Anneke Spoorenberg	2018	10
20	Extraskeletal Manifestations in Axial Spondyloarthritis Are Associated With Worse Clinical Outcomes Despite the Use of Tumor Necrosis Factor Inhibitor Therapy The Journal of Rheumatology ·R. van der Meer, Suzanne Arends, Sandra Kruidhof, Reinhard Bos, Hendrika Bootsma, F. Wink, Anneke Spoorenberg	2021	6

About F. Wink

F. Wink is a scholar working on Rheumatology, Immunology, Hematology, Orthopedics and Sports Medicine and Psychiatry and Mental health, having authored 44 papers that have together received 521 indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (37 papers), Psoriasis: Treatment and Pathogenesis (22 papers), Rheumatoid Arthritis Research and Therapies (18 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (8 papers), Autoimmune and Inflammatory Disorders Research (8 papers), Bone and Joint Diseases (6 papers), Musculoskeletal pain and rehabilitation (4 papers) and Hidradenitis Suppurativa and Treatments (3 papers). The work is most often cited by research in Rheumatology (439 citations), Orthopedics and Sports Medicine (117 citations), Immunology (227 citations), Hematology (98 citations) and Psychiatry and Mental health (86 citations). F. Wink has collaborated with scholars based in Netherlands, United States and Italy. Frequent co-authors include Suzanne Arends, Anneke Spoorenberg, Hendrika Bootsma, F. Maas, Elisabeth Brouwer, E. van der Veer, Reinhard Bos, M. Efdé, P. M. Houtman and Davy Paap. Their work appears in journals such as Annals of the Rheumatic Diseases, Seminars in Arthritis and Rheumatism, PLoS ONE, Arthritis Research & Therapy and Arthritis Care & Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact